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 Brachytherapy or internal radiotherapy is one of many methods used for treatment 
of cancer. This modality requires an agent with radionuclides that emits α or β 
particle with a proper energy. 198Au (99% β max = 0.96 MeV and t1/2 = 2.69 days) is 
one of radionuclides that has been considered to be effective for the above-
mentioned purpose.  The purpose of this research was to synthesis and characterize 
poly(amidoamine) (PAMAM) G3.0 dendrimers encapsulated 198Au nanoparticles as 
a new brachytherapy agent. PAMAM G3.0 dendrimers encapsulated 198Au 
nanoparticles was successfully synthesized by a bottom-up method using sodium 
borohydride as a reductor. Purification was then performed by a size exclusion 
chromatography in order to separate large Au nanoparticles that were formed 
outside the cavity of PAMAM G3.0 dendrimers. Prior to the synthesis of PAMAM 
G3.0 dendrimers encapsulated 198Au nanoparticles, the synthetic procedure was first 
established by using a non-radioactive Au. The PAMAM G3.0 dendrimers 
encapsulated Au nanoparticles produced was then characterized by using an UV-Vis 
spectroscopy, a transmission electron microscopy (TEM), particle size analyzer 
(PSA), and an atomic absorption spectroscopy (AAS). Characterization results 
revealed that PAMAM G3.0 dendrimers encapsulated Au nanoparticles that were 
prepared from a reaction mixture of PAMAM G3.0 dendrimers and Au HAuCl4 
with mol ratio of 2.8, was found to be a proper formula.  It produced PAMAM G3.0 
dendrimers encapsulated Au nanoparticles with diameter of 1.743 nm, spheris, 
uniform and drug loading value of 26.34%. This formula was then used in synthesis 
using radioactive Au, 198Au.  Characterization results of PAMAM G3.0 dendrimers 
encapsulated 198Au nanoparticles gave a radiochemical purity of 99.4% and zero 
charge.   
 
© 2012 Atom Indonesia. All rights reserved
 
INTRODUCTION∗ 
 
Cancer is a disease that threatens human life.  
It has been reported that there were 12 millions of  
new cancer cases in 2008, with the number of deaths 
of 7.5 millions of 6 billions total world cancer 
population [1]. Meanwhile in Indonesia in 2008 
there were a number of 292.6 thousands new cancer 
cases with the number of death of 21.4 thousands of 
227 millions Indonesia cancer population [1]. 
Therefore a lot of attention for curing the disease 
has gained every single year.  
Radiotherapy is one of cancer treatment 
                                                
∗ Corresponding author. 
   E-mail address: rienrita@batan.go.id 
methods that has been resulting different of 
therapeutic success [2]. It is based on the use of 
radiation which is emitted by radioactive 
substances. 
One type of radiotherapy is internal 
radiotheraphy which is also known as 
brachytherapy. Brachytherapy could be used to treat 
various types of solid cancers, such as prostate, 
cervix, breast, and others. Brachytherapy is 
performed by placing radioactive material inside or 
near the tumor temporaly or permanently using a 
catheter [3]. Brachytherapy is generally perfomed 
by using micro-sized radioactive seed (50-100 µm) 
made of 125I, 103Pd or 90Y (Therasphere ™) [4].  
Radionuclides of gold, 198Au [4], has been 
used for brachytherapy since 1950 [2]. This 
Atom Indonesia Vol. 38  No. 3  (2012) 118 - 126 
 
118 
R. Ritawidya, et al. / Atom Indonesia Vol. 38  No. 3  (2012) 118 - 126 
 
application is due to its physical properties that are 
attractive for the above-mentioned purpose. 198Au 
with a half life (t1/2) of 2.7 days, emits β particle 
(99% β max = 0.96 MeV) which is ideal for 
radiotherapy of cancer. It also emits γ radiation; 
(0.98% γ = 1.1 MeV), which is also ideal for 
dosimetry, pharmacokinetics and imaging studies 
[5].  It has been reported by Loening that a direct 
delivery of radionuclides 198Au to cancer cells was 
found to be quite successful in eradicating cancer 
cells [6], however the delivery was constrained by 
the limited doses of 198Au activity which was able to 
be deposited inside or near cancer cells.                    
This limitations could be overcome by 
encapsulating a number of 198Au nanoparticles 
inside the cavity of dendrimers.  
One of the ideal drug delivery carriers that 
has been widely used is dendrimer [5]. This 
substance is a macromolecule that has nano 
structures [7], globular-shaped, has monodispersity 
in size, and functional groups on its surface [8].  
Dendrimer structure consists of three main parts, 
namely the structure of the nucleus (core), 
branching (generation), and surface functional 
groups [9]. The advantages of dendrimer beside its 
nano-scale size is its ability to encapsulate an 
organic or inorganic molecules and metal 
nanoparticles that is referred to an unimolecular 
encapsulation in its internal interior or known as 
cavity [10]. P(olyamidoamine) dendrimer- Ethylene 
Diamine (EDA) core with amine functional groups 
(PAMAM) dendrimers is a type of dendrimers that 
has been widely used as drug delivery agent in the 
biomedicine field because of its biocompatibility 
and low immunogenicity [8,11].  The 3rd generation 
PAMAM (G3.0) is known to have characteristics 
that suitable for in vivo application [12]. Structure 
of PAMAM G3.0 dendrimer can be seen in              
Fig. 1 [13]. 
PAMAM G3.0 dendrimers encapsulated 
198Au nanoparticles is one example case of 
unimolecular encapsulation method. The advantage 
of this method is that the outer layer of PAMAM            
G 3.0 dendrimer does not change so that the outer 
layer can still interact with body tissues. Therefore 
by this method, the radioactivity dose of PAMAM 
G3.0 dendrimers encapsulated 198Au nanoparticles 
can be delivered to the target (cancer cells) 
effectively. 
198Au nanoparticles consist of at least 20000 
of Au atoms that can kill and destruct cancer more 
powerful [14]. Dendrimers have also been widely 
used as a template to control size and dispersity of 
Au nanoparticles as well as play role as a stabilizer 
in the synthesis because Au nanoparticles tend to 
agglomerate [15-17]. 
 
Fig. 1. The structure of PAMAM G3.0 dendrimers[13]. 
 
Preparation of PAMAM dendrimer 
encapsulated nanoparticles 198Au was reported can 
be obtained by two methods [5]. Firtsly by 
irradiating the prepared PAMAM dendrimer 
encapsulated Au nanoparticles where PAMAM 
dendrimer encapsulated Au nanoparticles is 
prepared by reacting non radioactive (cold) Au (Au) 
in form of [AuCl4]-  with PAMAM dendrimers 
which then followed by a reduction of Au (III) into 
Au (0) nanoparticles by addition of sodium 
borohyride (NaBH4) [5]. Secondly, by reacting a 
[198AuCl4]-  with dendrimers where [198AuCl4]- was 
obtained from irradiating gold foil [5] in a            
nuclear reactor facility. Similar to the above-
mentioned, PAMAM dendrimers encapsulated 198Au 
nanoparticles also undergoes reduction process by 
addition NaBH4 as a reductor to change Au (III) into 
Au (0) nanoparticles [15]. In order to obtain an 
acceptable PAMAM dendrimers encapsulated 198Au 
nanoparticles a purification process is performed.   
A common method for purification of PAMAM 
dendrimers encapsulated 198Au nanoparticles is               
by using a size exclusion chromatography (SEC) 
[18,19]. 
The purpose of this study was to synthesis of 
PAMAM G3.0 dendrimer encapsulated 198Au 
nanoparticles which was expected to be used as 
brachytherapy agents for cancer theraphy, 
particularly for prostate cancer. In this study 
PAMAM G3.0 dendrimer encapsulated 198Au was 
prepared in similar way with the reported method, 
by reacting a [198AuCl4]- [2] and PAMAM G3.0 
dendrimers. The resulted product was then 
undergoing reduction process by addition NaBH4 as 
a reductor to change Au (III) into Au (0) 
nanoparticles [15]. Purification of  PAMAM G3.0 
dendrimer encapsulated 198Au was performed                
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by using a commercial SEC column PD-10 
(Sephadex G25). 
 
 
EXPERIMENTAL METHOD 
 
Materials used in this study included 
PAMAM G3.0, bovine serum albumin (BSA), gold 
chloride (HAuCl4.3H2O), methanol, and Au foil 
were obtained from Sigma-Aldrich. Hydrochloric 
acid, nitric acid, sodium borohidride (NaBH4), 
sodium phosphate dibasic (Na2HPO4.2H2O), sodium 
phosphate monobasic (NaH2PO4.H2O), and 
Whatman paper No 1 were purchased from Merck.  
Aquabidest and saline solution were obtained from 
IPHA, and PD-10 column (contain Sephadex G25 
medium) was from GE Healthcare. Au-198 foil was 
prepared by irradiating of Au foil at the G.A. 
Siwabessy, Multi Purposes Reactor. 
Equipment used in this study were hotplate 
magnetic stirrer (Cimarec), UV-Visible 
spectroscopy from (Jasco V-550), Atomic 
Absorption Spectroscophy AA 6300 (Shimadzu), 
dose calibrator (gamma ionisation chamber) 
(Atomlab100 plus Biodex Medical System), 
Transmission Electron Microscopy (TEM) JEM 
1400 (JEOL Ltd), electrophoresis EC 1000 XL 
(Thermo Scientific), Single Channel Analyzer 
(Bioscan), and Zeta Sizer Nano ZS (Malvern). 
 
 
Methods 
 
Prior to synthesis of PAMAM G3.0 
dendrimers encapsulated radioactive Au (198Au) 
nanoparticles, the synthesis was established by 
performing a non active procedure.  
 
 
Preparation of HAuCl4  
 
Gold foil (20.1 mg) was dissolved in 5 mL 
aqua regia, the solution was then heated and stirred 
untill almost dried. It was then redissolved with 10 
mL water, reheated with stirring untill almost dried 
(these steps were repeated three times). Finally, the 
residue was reconstituted in aliquot of 0.01 M HCl 
to give 0.002 M HAuCl4. The solution was then 
characterized using UV-Vis spectroscopy. 
 
 
Synthesis of PAMAM G3.0 dendrimers 
encapsulated Au nanoparticles  
 
The methods used similar to that of reported 
by to Ezumi et al. [15] with some modifications.             
A series of HAuCl4 solution, consisted of 0.002; 
0.001; 0.0005 M HAuCl4 and a series of PAMAM 
G3.0 consisted of 0.0014 and 0.0028 M PAMAM 
G3.0. The reactions were performed by addition of 
HAuCl4 to PAMAM G3.0 solutions to give reaction 
mixtures as follow: F1 (0.0014 M PAMAM G3.0 + 
0.002 M HAuCl4 solution , to give a final molar 
ratio of PAMAM to HAuCl4 = 0.7); F2 (0.0014 M 
PAMAM G3.0 + 0.001 M HAuCl4 solution, to give 
a final molar ratio 1.4); F3 (0.0014 M PAMAM 
G3.0 solution + 0.0005 M HAuCl4 solution, to give 
a final molar ratio 2.8); F4 (0.0028 M PAMAM 
G3.0 solution + 0.002 M HAuCl4 solution, to give a 
final molar ratio of 1.4); F5 (0.0028 M PAMAM 
G3.0 solution + 0.001 M HAuCl4 solution, to give a 
final molar ratio of 2.8); and F6 (0.0028 M 
PAMAM G3.0 solution + 0.0005 M HAuCl4 
solution, to give a final molar ratio of 5.6).                
The reaction mixtures were left to react for 15 mins 
by a stirring at room temperature and protected  
from light.  Aliquot amount of 0.02 M NaBH4 
solution was then added to the reaction mixtures 
which were then left to react for 48 hours.               
The reaction mixture was then characterized using 
UV-Vis spectroscopy.  
 
 
Purification of PAMAM G3.0 dendrimers 
encapsulated Au nanoparticles 
 
PAMAM G3.0 dendrimers encapsulated Au 
nanoparticles was purified from larger Au (> 2 nm) 
nanoparticles that was formed outside PAMAM G3 
cavity using PD-10 column.  The PD-10 column 
prior to its use were pre-blocked and pre-equibrated 
with 1 mL of 0.5% BSA and.01 M PBS pH 7.5 
respectively. One mL of PAMAM G3.0 dendrimers 
encapsulated Au nanoparticles sample was               
loaded onto the top of the column. The column was 
then eluted with 0.01 M PBS pH 7.5 and fractions       
(1 mL/ fraction) were retrieved. About 10 fractions 
were collected and characterized using a Biorad dye. 
 
 
Determination of the fraction containing 
PAMAM G3.0 dendrimers encapsulated Au 
nanoparticles 
 
In order to determine which fraction 
containing PAMAM G3.0 dendrimers encapsulated 
Au nanoparticles, a 10 µL from each fraction               
was pipet out and transferred into a 96-well plate.               
To each sample was then to 90 µL of a Biorad              
dye solution (diluted ¼). The colorless samples 
which that changed to blue indicated that               
they contained PAMAM G3.0 dendrimers 
encapsulated Au nanoparticles. These fractions were 
then used for further characterization which 
included morphology, average diameter, and 
120 
R. Ritawidya, et al. / Atom Indonesia Vol. 38  No. 3  (2012) 118 - 126 
 
entrapment eficiency by using TEM, PSA, and 
AAS, respectively. 
 
 
Synthesis of PAMAM G3.0 dendrimers 
encapsulated 198Au nanoparticles “hot 
procedure” 
 
Preparation of H198AuCl4 from Au foil.  
 
The Au foils were irradiated in rabbit facility 
of the GA Siwabessy Multi Purposes reactor, 
Serpong with 1.2 x 1013 n/cm2/s neutron flux for five 
hours. Radioactive Au foil (198Au) was treated in the 
hot cell facility which is similar to the working step 
for preparation of HAuCl4 solution. Radioactivity of 
H198AuCl4 was measured with dose calibrator. 
Radiochemical purity and charge of H198AuCl4 
solution were characterized with thin layer 
chromatography by using a Whatman paper No. 1 as 
a stationary phase and methanol 70% as mobile 
phase. The charge of H198AuCl4 solution was 
measured with electrophoresis by using a Whatman 
paper No.1 and phosphate buffered 0.01 M pH 7.5 
as a stationary phase and phase respectively.                
The chromatographic profiles of these papers were 
then measured by using BioScan TLC scanner. 
 
 
Synthesis of PAMAM G3.0 dendrimers 
encapsulated 198Au nanoparticles.  
 
The synthesis of PAMAM was carried out 
with the same procedure for the synthesis of non 
radioactive PAMAM G3.0 dendrimers encapsulated 
Au nanoparticles. 
 
 
Purification of PAMAM G3.0 dendrimers 
encapsulated 198Au nanoparticles 
 
Purification of 198Au nanoparticles  
encapsulated PAMAM G3.0 performed in the same 
way as for non-radioactive PAMAM G3.0 
dendrimers encapsulated Au nanoparticles. The 
sample obtained were analyzed by TLC and 
electrophoresis. The chromatographic profiles of 
these were measured using by Bioscan TLC 
scanner. 
 
 
RESULTS AND DISCUSSION 
 
Prior to synthesis of PAMAM G3.0 
dendrimers encapsulated radioactive gold (198Au) 
nanoparticles, the synthetic procedure was firstly 
established by optimizing the non-radioactive 
procedure. The established procedure was then 
applied for preparation PAMAM G3.0 dendrimers 
encapsulated radioactive 198Au nanoparticles.              
The reason for firstly establishing the non-
radioactive procedure was mainly due to the 
difficulty in characterization of radioactive samples 
with several systems such as TEM, PSA, and AAS.  
Therefore, by preparing PAMAM G3.0 dendrimers 
encapsulated non radioactive Au nanoparticles and 
establishing its preparation procedure which 
resulted in non radioactive product, it made possible 
to perform the above–mentioned characterizations.   
Preparation of PAMAM G3.0 dendrimers 
encapsulated non radioactive Au nanoparticles was 
initiated by preparation of HAuCl4 solution which 
was done by dissolving the gold foils in aqua regia. 
The nitroso was eliminated from gold solution by 
heating the gold solution untill dried. Au3+ solution 
formed a stable complex solution [AuCl4]-. Finally it 
was reconstituted in 0.01 M HCl to give 0.002 M 
HAuCl4 solution. Absorbance of the prepared 
HAuCl4 solution was then measured with UV-Vis 
spectrophotometer. The UV-Vis spectra of HAuCl4 
solution from Au foil in Fig. 2 showed the same 
absorption peaks as peak absorption of standard 
HAuCl4 solution at λ 312 nm. This proved that 
preparation of HAuCl4 solution from Au foil in this 
study had been successful. 
Ezumi et al. [15] studied the preparation of 
gold-dendrimer nanocomposite by reduction of 
[AuCl4]- with sodium borohydride (NaBH4) in the 
presence of dendrimer. In this study however, the 
synthesis method was performed with a bottom-up 
method, in which a solution HAuCl4 was reacted 
with PAMAM G3.0 dendrimer which was then 
followed by addition of NaBH4 as a reductor.              
The color change after addition of NaBH4 was 
observed indicating the formation of Au (0) 
nanoparticles.  The yellow color of HAuCl4 turned 
into ruby colour as a result of surface plasmon 
resonance (SPR) [20,21]. The spectra of F1, F2, and 
F3 shown in Fig. 3 did not give a peak absorption of 
HAuCl4 at λ 312 nm which indicated that Au (III) 
was succesfully reducted into Au (0) nanoparticles.  
 
 
 
Fig. 2. Spectra of standard HAuCl4 in HCl 0.01 M (A) and 
HAuCl4 from Au foil (B). 
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Fig. 3. Spectra of HAuCl4, PAMAM G3.0, F1, F2, and F3 (a). 
Spectra of HAuCl4, PAMAM G3.0, F4, F5, and F6 (b). 
 
It can be seen in Fig. 3 that F1, F2, and F3 
spectra gave the same pattern with the absorption 
peak at λ 280 nm and λ 514 nm. SPB at around               
λ 514 nm also indicated the formation of Au (0) 
nanoparticles that was larger than 2 nm in diameter 
and formed outside the cavity of PAMAM G3.0 
dendrimers [8]. These spectra revealed that the 
increasing of molar ratios of PAMAM G3.0 
dendrimers towards HAuCl4 in F1, F2, and F3 
reaction mixtures (0.7, 1.4 and 2.8) increased the 
absorption at the λ 280 nm and λ 514 nm.  Similar 
pattern was also obtained in F4, F5, and F6 (molar 
ratios of PAMAM G3.0 dendrimers towards 
HAuCl4 were 1.4, 2.8 and 5.6 respectively).  
Synthesis of PAMAM G3.0 dendrimers 
encapsulated Au nanoparticles according to Khan           
et al. [5] consisted of three-step reaction: 1) 
formation coordination complex between free 
electron of interior tertiary amine PAMAM 
dendrimer with [AuCl4]- ion; 2) decomposition of 
the complex; 3) reduction of Au3+ to Au (0) 
nanoparticles with the addition of NaBH4. In this 
study PAMAM G3.0 dendrimer was used as a 
template to control the growth of Au nanoparticles.  
Therefore, Au (0) nanoparticles was formed and 
trapped in the cavity of PAMAM G3.0 dendrimer. 
The size of PAMAM is indicated by its 
generation. Higher generation of PAMAM has 
bigger diameter size compared to that of lower 
generation [9]. PAMAM G5.0 which has a diameter 
of approximately 50 0A or 5 nm will have the ability 
to encapsulate Au nanoparticles measuring of              
1-3 nm in its cavity [20]. Therefore, PAMAM G3.0 
which has a diameter of 3.6 nm is expected to 
encapsulate Au nanoparticles that are smaller than 
2.0 nm in its cavity. In order to remove Au 
nanoparticles that are larger than 2.0 nm the raw 
product of PAMAM G3.0 dendrimers encapsulated 
Au nanoparticles needs to be purified. by               
SE-Chromatography (SEC) by a using PD-10 
column is aimed to eliminate the Au nanoparticles 
which have diameter larger than 2 nm.  
In this research purification of PAMAM G3.0 
dendrimers encapsulated Au nanoparticles was 
performed by SEC Chromatography a using PD-10 
column. The raw product of PAMAM G3.0 
dendrimers encapsulated Au nanoparticles PD-10 
column pre blocked with BSA and pre-equibrated  
with 0.01 M PBS pH 7.5. About 10 fractions (1 mL/ 
fraction) were collected and then analyzed with  
UV-Vis spectroscopy. In the SEC method, 
compounds with larger molecular weight will be 
eluted first, while the compounds with smaller 
molecular weight will eluted later. The results of 
UV-Vis spectroscopy analysis showed that fractions 
4 indicated the presence of PAMAM G3.0 
dendrimers encapsulated Au nanoparticles. This 
fraction did not show any absorption at 514 nm 
which was a characteristic of Au (0) nanoparticles 
with diameter larger than 2 nm and is not 
encapsulated by PAMAM G3.0 dendrimers.              
The existence of PAMAM G3.0 dendrimers 
encapsulated Au (0) nanoparticles in this fractions 
was also confirmed by colorimetric test. This 
fraction and PAMAM G3.0 solution gave a same 
color, blue, when treated with BioRad dye solution.  
In order to determine the morphology of 
PAMAM G3.0 dendrimers encapsulated Au 
nanoparticles which were produced from reaction 
mixture of F1, F2, F3, F4, F5, and F6.  The purified 
PAMAM G3.0 dendrimers encapsulated Au 
nanoparticles were tested by using a TEM and their 
images were showed in Fig. 4. As it can be seen in 
Fig. 4 that the morphology of PAMAM G3.0 
dendrimers encapsulated Au (0) nanoparticle 
generated from F1 and F4 solutions were less 
uniform and spheris Au (0). The morphology of 
PAMAM G3.0 dendrimers encapsulated Au (0) 
nanoparticle generated from F2, F3, F5, and F6 
solutions however were a uniform and spheris. This 
is influenced by the HAuCl4 concentration, where a 
smaller concentration was used the more uniform 
morphology was obtained.  
The average diameter of Au (0) nanoparticles 
and the entrapment eficiency were analyzed using 
PSA and AAS, respectively.  The average diameter 
of PAMAM G3.0 dendrimers encapsulated Au (0) 
nanoparticles generated from F1, F2, F3, F4, F5, 
and F6 solutions were 3.299 nm, 201.2 nm, 0.7141 
nm, 1.808 nm, 1.743 nm, and 4.199 nm, 
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respectively. The entrapment efficiency of PAMAM 
G3.0 dendrimers encapsulated Au (0) nanoparticle 
generated from F1, F2, F3, F4, F5, and F6 solutions 
which were measure by AAS were 1.24, 4.45, 3.3, 
0.41, 26.34, and 8.26% respectively.  It can be seen 
that the increasing molar ratios of PAMAM G3.0 
dendrimers towards HAuCl4 decreased the average 
diameter of PAMAM G3.0 dendrimers encapsulated 
Au (0) nanoparticles obtained except for F2 and F6 
which had the average diameter of 201.2 nm and 
4.199 nm, respectively. Anomaly was found for 
PAMAM G3.0 dendrimers encapsulated Au (0) 
nanoparticles generated from F2 solution.  This was 
suspected to be caused by several factors, among 
others, the occurrence of Au nanoparticles 
agglomeration, microbial contamination or the dust 
that interfere with the analysis process [22]. 
Therefore, it is important to strengthen the analytical 
results of this PSA with other nanoparticles 
characterization techniques such as TEM.  
 
 
 
Fig. 4. The morphology images of PAMAM G3.0 dendrimers 
encapsulated Au (0) nanoparticle generated from (a) F1, (b), F2, 
(c) F3, (d) F4, (e) F5 and (f) F6 solutions. 
 
It has been mentioned before that 
nanoparticles with the average size larger than 2.0 
nm were not encapsulated by PAMAM G3.0. There 
are several possible interactions between Au 
nanoparticles with PAMAM G3.0, that is through its 
interaction with the tertiary amine in the interior or 
cavity of PAMAM G3.0. Another is the interaction 
of Au nanoparticles with the primary amine surface 
of the PAMAM G3.0 or exterior amine functional 
groups [20].  Characterization by using particle size 
analyzer revealed that Au (0) nanoparticles derived 
from F1, F2, and F6 solutions were formed in the 
cavity of PAMAM G3.0 dendrimers, but Au (0) 
nanoparticles derived from F3, F4, and F5 solutions 
showed that formation of Au (0) nanoparticles           
were outside the cavity of PAMAM G3.0 
dendrimers. The analysis of Au (0) nanoparticles 
interaction with PAMAM G3.0 dendrimers still 
need a further study.  
Based on the above results, purification 
carried out by PD-10 column was a quite effective 
method for separation of PAMAM G3.0 dendrimers 
encapsulated Au (0) nanoparticles from Au 
nanoparticles that are smaller than 2.0 nm as it was 
supported and confirmed by TEM characterization 
results.  It could also be seen that the molar ratios of 
PAMAM G3.0 dendrimers to Au3+ influenced not 
only the amount of Au (0) nanoparticles that 
entrapped in the cavity of PAMAM G3.0 
dendrimers but also the morphology and the average 
diameter.  The preliminary study also showed that 
the best formulation for preparation PAMAM G3.0 
dendrimers encapsulated Au (0) nanoparticles was 
F5 solution where molar ratio of PAMAM G3.0 
dendrimers towards HAuCl4 was 2.8,  because this 
formulation was able to produce PAMAM G3.0 
dendrimers encapsulated Au (0) nanoparticles with 
the adsorption efficiency value of 26.34%, the size 
of Au nanoparticles that are less than 2 nm, and a 
spherical morphology and uniform.  It was therefore 
this formulation was then used for preparation of 
PAMAM G3.0 dendrimers encapsulated 198Au (0) 
nanoparticles. 
 
 
Synthesis of PAMAM G3.0 dendrimers 
encapsulated 198Au nanoparticles “hot 
synthesis”. 
 
Synthesis of PAMAM G3.0 dendrimers 
encapsulated 198Au nanoparticles can be done in two 
ways, first by irradiating the Au nanoparticles-
PAMAM G3.0, and second by using the solution of 
H198AuCl4. This study used the later method, as 
there are some disadvantages when irradiating the 
PAMAM G3.0 dendrimers encapsulated Au 
nanoparticles. The disadvantages that had reported 
were the formation of radical product, expansion of 
molecules, etc [5]. Preparation of H198AuCl4 
solution was carried out by irradiating Au foil 
(197Au) in the GA Siwabesy Multi Purposes Reactor 
with neutron capture reaction, with neutron flux of 
123
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1.2 x 1013 n/cm2/s for five hours. Isotope 197Au is a 
stable isotope with a large abundance in nature 
(˜99.99%). If 197Au captures neutron, it will produce 
198Au radioisotope [23]. Neutron capture reaction  
(n, γ) can be performed due to the large cross 
section reaction of 197Au, 98.65 barn (1 barn = 10-24 
cm2) [23]. 
 
 
Fig. 5. Radiochromatogram of H198AuCl4 solution (a) analysed 
with TLC and (b) analyzed with electrophoresis. 
 
Preparation of [198AuCl4]- from Au foil 
resulted in a high purity of 198Au radionuclide.  The 
preparation of [198AuCl4]- was carried out in the 
same manner as the preparation of the non-
radioactive [AuCl4]- solution. 198Au foil was 
dissolved in aqua regia and the [198AuCl4]- solution 
produced was then analyzed by a dose calibrator to 
measure it radioactivity. In order to determine its 
chromatographic profile [198AuCl4]- solution was 
also analyzed by a thin layer chromatography (TLC) 
as well as electrophoresis. The TLC of [198AuCl4]- 
solution  which was carried on a Whatman paper 
No. 1 and 70% of methanol as stationary and mobile 
phase, respectively gave a chromatogram with Rf of 
0.77, shown in Fig. 5a. Analysis of [198AuCl4]- with 
electrophoresis by using a Whatman paper No. 1 
and 0.01 M phosphate buffer pH 7.5 gave a 
chromatogram shown in Fig. 5b. This 
chromatogram indicated that [198AuCl4]- was the 
only species in the H198AuCl4 solution which was 
prepared from Au foil.  
Synthesis of PAMAM G3.0 dendrimers 
encapsulated 198Au nanoparticles from [198AuCl4]-  
was conducted using F5 solution formula (molar 
ratio PAMAM G3.0 dendrimers to 198Au/Au was 
2.8) where radioactivity of [198AuCl4]- used was of 
175.8 µCi. After reduction the raw product of 
PAMAM G3.0 dendrimers encapsulated 198Au 
nanoparticles was purified with SEC using a           
PD 10 column. Ten fractions (1 mL / fractions)  
were   retrieved   from   this  purification   process. 
 
 
Fig. 6. (a) Radiochromatogram of purification using PD-10 
column, (b) Radiochromatogram of fraction 4 analyzed with 
TLC, (c) Radiochromatogram of Fraction 4 analyzed with 
Electrophoresis. 
 
Figure 6a shows the radiochromatogram of 
PAMAM G3.0 dendrimers encapsulated 198Au 
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nanoparticles purification. It can be seen from this 
chromatogram having a peak at fraction 4. When 
aliquot of this fraction was tested with Bio-Rad dye 
solution, it gave a blue color which indicated the 
existence of PAMAM G3.0 dendrimers. This 
fraction was then further analyzed with TLC by 
using a Whatman paper No. 1 and 70% of methanol 
as stationary and mobile phase, respectively and 
electrophoresis by using Whatman paper No.1 and 
phosphate buffer 0.01 M pH 7.5. The 
chromatograms of fraction 4 which were generated 
from the above-mentioned analysis were shown in 
Fig. 6b (TLC) and 6c (Electrophoresis).  It can be 
seen in Fig. 6b that Rf of fraction 4 was 0. This 
indicated there was no more [198AuCl4]-  (Rf > 0.7) 
species in this fraction.  It also can be seen in Fig. 6c 
that fraction 4 had a zero charged. Based the above 
data it could be proved that the species that was 
exist in fraction 4 was of PAMAM G3.0 dendrimers 
encapsulated Au nanoparticles and the 
radiochemical purity of PAMAM G3.0 dendrimers 
encapsulated Au nanoparticles was found to be 
99.4% and zero charged.  
 
 
CONCLUSION 
 
Synthesis of PAMAM G3.0 dendrimers 
encapsulated 198Au nanoparticles was successfully 
performed by using a bottom-up method which             
was previously established by using non-radioactive 
Au. Synthesis of PAMAM G3.0 dendrimers 
encapsulated non-radioactive Au nanoparticles was 
carried out prior to the synthesis of PAMAM G3.0 
dendrimers encapsulated 198Au nanoparticles in 
order to be able to fully characterize the of PAMAM 
G3.0 dendrimers encapsulated Au nanoparticles 
produced. The PAMAM G3.0 dendrimers 
encapsulated non-radioactive Au nanoparticles             
was most effective when prepared from PAMAM 
G3.0 dendrimers and HAuCl4 with molar ratio               
of 2.8.  Purification with SEC method by using            
PD-10 was proved to be quite effective to purify 
PAMAM G3.0 dendrimers encapsulated non-
radioactive Au nanoparticles from Au nanoparticles 
> 2 nm.  Characterization by TEM, PSA and AAS 
revealed that PAMAM G3.0 dendrimers 
encapsulated non-radioactive Au nanoparticles 
produced  were uniform and spheris which had a 
diameter < 2 nm and encapsulated in interior or 
cavity PAMAM G3.0. PAMAM G3.0 dendrimers 
encapsulated 198Au nanoparticles which was 
prepared precisely in a similar manner                     
with the preparation PAMAM G3.0 dendrimers 
encapsulated non-radioactive Au nanoparticles were 
found to have radiochemical purity of  
radiochemical purity of 99.4% and zero charge. 
Future research to find out  the stability of 
PAMAM G3.0 dendrimers encapsulated 198Au in 
vitro and in vivo using tumor cell line and animal 
model, respectively, need to be carried out. 
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